We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
26
United Therapeutics
UTHR
$22.7B
$32.3M 1.07%
212,954
+19,992
+10% +$2.62M
AVNT icon
27
Avient
AVNT
$3.39B
$31.9M 1.06%
792,730
+218,364
+38% +$7.7M
EYE icon
28
National Vision
EYE
$1.66B
$31.7M 1.05%
700,987
+49
+0% +$2.13K
COHR icon
29
Coherent
COHR
$54.3B
$31.5M 1.05%
415,103
-724
-0.2% -$42.9K
RARE icon
30
Ultragenyx Pharmaceutical
RARE
$2.88B
$31.4M 1.04%
+226,875
New +$26.9M
FIVE icon
31
Five Below
FIVE
$11.2B
$30.2M 1%
172,436
-16,885
-9% -$2.5M
ATRC icon
32
AtriCure
ATRC
$1.77B
$29.8M 0.99%
536,099
+35,251
+7% +$1.52M
RAMP icon
33
LiveRamp
RAMP
$2.3B
$28.9M 0.96%
395,290
+74,121
+23% +$4.72M
CCXI
34
DELISTED
ChemoCentryx, Inc.
CCXI
$28.7M 0.95%
463,961
+78,855
+20% +$4.51M
EBC icon
35
Eastern Bankshares
EBC
$4.94B
$28.6M 0.95%
+1,753,456
New +$24.9M
PLNT icon
36
Planet Fitness
PLNT
$4.14B
$28.6M 0.95%
367,825
-93,075
-20% -$6.51M
KPTI icon
37
Karyopharm Therapeutics
KPTI
$216M
$28.2M 0.94%
121,519
+14,635
+14% +$3.39M
QTWO icon
38
Q2 Holdings
QTWO
$3.43B
$28.2M 0.93%
222,613
-927
-0.4% -$99.8K
ARNA
39
DELISTED
Arena Pharmaceuticals Inc
ARNA
$28M 0.93%
364,392
+248,747
+215% +$18.6M
IMVT icon
40
Immunovant
IMVT
$8.27B
$27.9M 0.93%
603,670
+62,606
+12% +$2.89M
MODN
41
DELISTED
MODEL N, INC.
MODN
$27.7M 0.92%
776,707
-10,162
-1% -$352K
YETI icon
42
Yeti Holdings
YETI
$3.87B
$26.6M 0.88%
389,114
+34
+0% +$2.01K
LSCC icon
43
Lattice Semiconductor
LSCC
$17.2B
$26.5M 0.88%
578,415
+959
+0.2% +$37.1K
IBP icon
44
Installed Building Products
IBP
$6.16B
$25.7M 0.85%
252,456
-1,181
-0.5% -$121K
AZEK
45
DELISTED
The AZEK Co
AZEK
$25.4M 0.84%
660,904
+4,650
+0.7% +$168K
ADUS icon
46
Addus HomeCare
ADUS
$2.14B
$25.1M 0.83%
214,548
+507
+0.2% +$52.3K
VIAV icon
47
Viavi Solutions
VIAV
$9.41B
$24.9M 0.83%
1,660,296
-18,534
-1% -$246K
OCUL icon
48
Ocular Therapeutix
OCUL
$1.96B
$24.6M 0.82%
+1,190,703
New +$17.7M
ONTO icon
49
Onto Innovation
ONTO
$13.9B
$24.2M 0.8%
509,882
+160,113
+46% +$6.42M
SMTC icon
50
Semtech
SMTC
$11.6B
$23.9M 0.79%
331,788
+46,294
+16% +$2.96M
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.